Efficacy of a combination therapy using Listeria has been recently shown in transplantable HCC model [44] and in LmAI-based Annexin A2-targeting cancer immunotherapy in pancreatic cancer models [45]. The gene discussed is ANXA2; the disease is hepatocellular carcinoma.